INFLUENCE OF AGE ON THE PHARMACOKINETICS OF ALFENTANIL - GENDER DEPENDENCE

被引:53
|
作者
LEMMENS, HJM
BURM, AGL
HENNIS, PJ
GLADINES, MPPR
BOVILL, JG
机构
[1] Department of Anesthesiology, University Hospital Leiden, Leiden, 2300 RC
关键词
D O I
10.2165/00003088-199019050-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studies on the effects of age on the pharmacokinetics of alfentanil are inconclusive. A possible factor in explaining the differences between various studies could be the effect of gender. The authors studied the effects of age on the pharmacokinetics of alfentanil in female (n = 21) and male (n = 15) patients undergoing lower abdominal surgery under nitrous oxide alfentanil anaesthesia. There was a significant negative correlation (r = −0.79, p < 0.001) between plasma alfentanil clearance (CL) and age in women (<50y, median CL 24.84 L/h; >50y, median CL 14.52 L/h), but not in men (<50y, median CL 19.44 L/h; >50y, median CL 16.2 L/h). The conclusion is drawn that the effects of age on the pharmacokinetics of alfentanil are gender-dependent. © 1990, Adis International Limited. All rights reserved.
引用
收藏
页码:416 / 422
页数:7
相关论文
共 50 条
  • [21] ALTERED PHARMACOKINETICS OF ALFENTANIL
    ROBBINS, R
    WHALLEY, DG
    DONATI, F
    WYNANDS, JE
    RAMSAY, JR
    CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1986, 33 (03) : S103 - S104
  • [22] THE INFLUENCE OR AGE ON PHARMACOKINETICS
    UGES, DRA
    TGO-TIJDSCHRIFT VOOR THERAPIE GENEESMIDDEL EN ONDERZOEK JDR-JOURNAL FOR DRUGTHERAPY AND RESEARCH, 1987, 12 (02): : 50 - 54
  • [23] INTRAVENOUS ANESTHESIA WITH PROPOFOL AND ALFENTANIL - THE INFLUENCE OF AGE AND WEIGHT
    HILTON, P
    DEV, VJ
    MAJOR, E
    ANAESTHESIA, 1986, 41 (06) : 640 - 643
  • [24] The influence of age and gender on the likelihood of endorsing cannabis abuse/dependence criteria
    Delforterie, Monique J.
    Creemers, Hanneke E.
    Agrawal, Arpana
    Lynskey, Michael T.
    Jak, Suzanne
    Huizink, Anja C.
    ADDICTIVE BEHAVIORS, 2015, 42 : 172 - 175
  • [25] Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil .1. Model development
    Minto, CF
    Schnider, TW
    Egan, TD
    Youngs, E
    Lemmens, HJM
    Gambus, PL
    Billard, V
    Hoke, JF
    Moore, KHP
    Hermann, DJ
    Muir, KT
    Mandema, JW
    Shafer, SL
    ANESTHESIOLOGY, 1997, 86 (01) : 10 - 23
  • [26] BROMAZEPAM PHARMACOKINETICS - INFLUENCE OF AGE, GENDER, ORAL-CONTRACEPTIVES, CIMETIDINE, AND PROPRANOLOL
    OCHS, HR
    GREENBLATT, DJ
    FRIEDMAN, H
    BURSTEIN, ES
    VERBURGOCHS, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (07): : 556 - 556
  • [27] INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS OF ONDANSETRON, A 5HT3 ANTAGONIST
    PRITCHARD, JF
    BRYSON, JC
    KERNODLE, AE
    BENEDETTI, TL
    POWELL, JR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 161 - 161
  • [28] BROMAZEPAM PHARMACOKINETICS - INFLUENCE OF AGE, GENDER, ORAL-CONTRACEPTIVES, CIMETIDINE, AND PROPRANOLOL
    OCHS, HR
    GREENBLATT, DJ
    FRIEDMAN, H
    BURSTEIN, ES
    LOCNISKAR, A
    HARMATZ, JS
    SHADER, RI
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (05) : 562 - 570
  • [29] ARE THE PHARMACOKINETICS OF ALFENTANIL REALLY PREDICTABLE
    FISHER, DM
    ANESTHESIOLOGY, 1983, 59 (03) : 256 - 257
  • [30] ALFENTANIL PHARMACOKINETICS IN PRETERM INFANTS
    MARLOW, N
    WEINDLING, AM
    VANPEER, A
    HEYKANTS, J
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1990, 65 (04): : 349 - 351